Skip to main content
VCbacked
Log inGet Started

Raydiant Oximetry

San Ramon, United States

Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth.

$7.5M raised
Jun 2024
Series A
BiotechnologyHealth CareMedicalWomen's

Top Investors

National Science FoundationEnterprise IrelandMarch of DimesNational Institutes of HealthFemHealth Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Raydiant Oximetry

How much funding has Raydiant Oximetry raised?
Raydiant Oximetry has raised $7.5M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
Who are Raydiant Oximetry's investors?
Raydiant Oximetry's investors include National Science Foundation, Enterprise Ireland, March of Dimes, National Institutes of Health, FemHealth Ventures.
Where is Raydiant Oximetry headquartered?
Raydiant Oximetry is headquartered in San Ramon, United States.
What does Raydiant Oximetry do?
Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth.
What stage is Raydiant Oximetry at?
Raydiant Oximetry is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Raydiant Oximetry — Funding & Investors." VCBacked, June 4, 2024, https://www.vcbacked.co/company/raydiant-oximetry. Accessed June 4, 2026.
APA
VCBacked. (2024). Raydiant Oximetry — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/raydiant-oximetry
Wikipedia (cite web)
{{cite web |title=Raydiant Oximetry — Funding & Investors |url=https://www.vcbacked.co/company/raydiant-oximetry |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong